Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Nuvation Bio Inc. (NUVB) vs Urogen Pharma (URGN)

Nuvation Bio Inc. and Urogen Pharma are both Biotechnology companies. Nuvation Bio Inc. and Urogen Pharma are of similar size ($2.0B and $2.0B). Nuvation Bio Inc. grew revenue faster over the last twelve months: 1,083.6% against 100.3%. Urogen Pharma has the higher net margin (−51.7% vs −88.2%) and the higher return on invested capital (0.00% vs 0.00%). Across the 15 metrics below, Urogen Pharma leads on 8 and Nuvation Bio Inc. on 7.

Valuation

Metric NUVB URGN Biotechnology median
P/E n/m n/m 7.88
P/S 11.78 11.04 11.47
P/B 7.89 n/m 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m n/m 0.74
EV/Sales 9.36 11.47 10.73
Earnings yield (7.57%) (4.79%) (28.84%)
Free cash flow yield (6.04%) (7.64%) (23.03%)

Profitability

Metric NUVB URGN Biotechnology median
Gross margin 88.18% 90.85% 65.16%
Operating margin (81.00%) (35.32%) 0.00%
Net margin (88.19%) (51.73%) 0.00%
Free cash flow margin (71.17%) (84.32%) 0.00%
Return on equity (47.81%) 86.49% (57.72%)
Return on assets (21.53%) (42.33%) (49.22%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric NUVB URGN Biotechnology median
Revenue growth (TTM) 1,083.56% 100.27% 5.64%
EPS growth (last fiscal year) 71.56% (7.77%) —
Revenue growth, 5-year CAGR — 56.22% 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric NUVB URGN Biotechnology median
Debt to equity 0.98 (1.45) 0.00
Current ratio 8.37 3.80 4.73
Net debt to EBITDA 2.26 0.00 0.96

Dividend

Metric NUVB URGN Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric NUVB URGN Biotechnology median
Market cap 2.02b 2.02b 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack